Industry
Biotechnology
Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.
Total Companies
1 448
1 381 stocks
| Company | Last Price | Price Change | Market Cap | ||
|---|---|---|---|---|---|
|
|
|
Abbvie Inc
ABBV
|
$255.81 |
-2.7%
|
$452B |
|
|
|
Amgen Inc
AMGN
|
$431.635 |
-2%
|
$233B |
|
|
|
Gilead Sciences Inc
GILD
|
$145.55 |
-1.7%
|
$180.7B |
|
|
|
Vertex Pharmaceuticals Inc
VRTX
|
$542.49 |
-0.9%
|
$137.7B |
|
|
|
Regeneron Pharmaceuticals Inc
REGN
|
$794.035 |
-2.5%
|
$83.2B |
|
|
|
argenx SE
ARGX
|
€895.2 |
-0.3%
|
$65.4B |
|
|
|
CSL Ltd
CSL
|
AU$172.18 |
-0.2%
|
$59.1B |
|
|
|
Moderna Inc
MRNA
|
$138.1 |
-7.7%
|
$54.8B |
|
|
|
Natera Inc
NTRA
|
$327.47 |
-3.2%
|
$46.9B |
1 376 results hidden
Create a free account to unlock additional access and upgrade to see all results
Create Free Account
